About: Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $223.48 (-1.55%)
ASND NASDAQ Ascendis Pharma AS
Ascendis Pharma AS share price
ASND price activity
Last Price
$223.480
Change (24hr)
-3.52 USD (-1.55%)
Volume
343.41K
Volume (4w avg)
-
Open
$225.99
Day Range
$223.48 - $225.99
Previous Close
$227.00
Last Trade
13 Oct, 6:30 pm GMT+0
Delayed
13 Oct, 6:30 pm GMT+0
ASND price performance
Delayed
13 Oct, 6:30 pm GMT+0
ASND Market Signals